Is Posterior Circulation Stroke Reversible?
Yes, posterior circulation stroke can be reversible with timely endovascular thrombectomy (EVT), particularly for basilar artery occlusion (BAO), which dramatically improves clinical outcomes when performed within appropriate time windows.
Evidence-Based Treatment Approach
Time-Dependent Reversibility
The reversibility of posterior circulation stroke depends critically on rapid intervention:
Within 12 hours: Thrombectomy is definitively indicated for patients with acute BAO meeting specific criteria (NIHSS ≥6, PC-ASPECTS ≥6, age 18-89 years) 112. This represents Class I, Level B-R evidence based on the ATTENTION and BAOCHE randomized controlled trials.
12-24 hours: Thrombectomy remains reasonable with the same clinical criteria (Class IIa, Level B-R) 11. The BAOCHE trial specifically demonstrated benefit in this extended window.
Beyond 24 hours: Thrombectomy may be considered case-by-case (Class IIb, Level C-EO) 11. While isolated case reports show successful recanalization in 50% of patients treated beyond 24 hours, there is tremendous uncertainty about benefit in these extended windows 1.
Critical Patient Selection Criteria
For optimal reversibility, patients must meet:
- NIHSS score ≥6 (patients with NIHSS <10 showed no benefit from EVT over best medical treatment alone) 2
- PC-ASPECTS ≥6 (indicating limited established infarction)
- Confirmed basilar or vertebral artery occlusion on CTA 11
Important caveat: Data from the BASICS registry found that functional outcomes were universally poor when recanalization was achieved in patients with NIHSS ≤6, suggesting these patients may not benefit from aggressive intervention 1.
Combined Treatment Strategy
The optimal approach combines:
Intravenous thrombolysis (IVT) up to 24 hours from last known well, unless contraindicated 2. While no BAO-specific RCT data exist for IVT, expert consensus strongly supports its use based on historical standard of care and non-randomized studies showing high proportions of favorable outcomes.
IVT plus EVT is suggested over direct EVT alone 2, though this recommendation is based on very low certainty evidence.
Add-on antithrombotic treatment during or within 24 hours after EVT may be considered in patients without concomitant IVT when EVT is complicated by failed recanalization, imminent re-occlusion, or need for stenting 2.
Outcomes and Prognosis
Realistic Expectations
Research demonstrates that posterior circulation stroke treated with mechanical thrombectomy shows:
- Similar effectiveness to anterior circulation stroke 3
- Lower risk of symptomatic intracranial hemorrhage (0% vs 3% in anterior circulation) 3
- Favorable functional outcome (mRS 0-2) in 38-42% of patients at 3 months 3
- Mortality of approximately 30-34% 34
Territory-Specific Recurrence Patterns
Critical for long-term management: Recurrent stroke shows marked circulation concordance. After posterior circulation stroke, recurrent posterior circulation events occur in 12.9% over 2 years, compared to only 1.67% recurrent anterior circulation events 4. This supports circulation-aware risk stratification and targeted secondary prevention.
Common Pitfalls to Avoid
Underestimating severity: The conventional NIHSS may underestimate posterior circulation deficits involving vertigo, nystagmus, truncal ataxia, and bulbar dysfunction 5. Consider using expanded NIHSS or posterior circulation-specific scales.
Delayed diagnosis: Non-specific symptoms frequently delay BAO diagnosis, potentially pushing patients beyond optimal treatment windows 1.
Treating low NIHSS scores aggressively: Patients with NIHSS <10 showed no benefit from EVT and may actually fare better with medical management alone 2.
Missing posterior leukoencephalopathy syndrome: This potentially reversible syndrome can mimic posterior circulation stroke but requires aggressive blood pressure management rather than reperfusion therapy 6.
Geographic and Population Considerations
Important nuance: Treatment effects vary significantly based on:
- Geographic region (Europe vs Asia) 2
- Proportion of IVT in the best medical treatment arm 2
- High prevalence of intracranial atherosclerotic disease in Asian populations 2
These factors should inform individualized treatment decisions, particularly in borderline cases.